Fingerprint
Dive into the research topics of 'A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically